Trial Details
COMPLETEDBasic Information
| Clinical ID | c3482 |
|---|---|
| Identifier | NCT01981616 |
| Trial Title | Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | DRUG: Vedolizumab|DRUG: Placebo|BIOLOGICAL: Hepatitis B vaccine|BIOLOGICAL: Oral cholera vaccine |
Participant Information
| Sponsor | Millennium Pharmaceuticals, Inc. |
|---|---|
| City | Manchester |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2011-09 |
|---|---|
| Primary Completion Date | 2012-05 |
| Completion Date | 2012-07 |